The Patent Finder

Terms ending in 2044

Merck Sharp and Dohme LLC

Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2044, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,780,845Arginase Inhibitors and Methods of Use
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,643,904RIPK1 Inhibitors and Methods of Use
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,709,595Novel Synthetic Pathway to Belzutifan
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,565,494Inhibitors of Human Respiratory Syncytial Virus and Metapneumovirus
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,548,316Multi-Dimension Unified Swin Transformer for Lesion Segmentation
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,643,882Inhibitors of Human Respiratory Syncytial Virus and Metapneumovirus
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,782,372Robot Task Scheduler with Verified Audit Trail
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,466,840Small Molecule Inhibitors of Kras Proteins
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,697,308Novel Thermostable Lipid Nanoparticle and Methods of Use Thereof
In force
 · High confidence
MerckIn forceHigh confidence
9 of 9 patents shown. Soonest term end first, then patent number.
8 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited